Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Research Diagnostic Criteria
1978 • 6,988 citations
A Diagnostic Interview
1978 • 5,735 citations
Delineation of two drug-responsive anxiety syndromes
1964 • 903 citations
Functional Correlates of Serotonin 5-HT1Recognition Sites
1988 • 564 citations
Genetic Factors in Anxiety Disorders
1983 • 527 citations
Serotonin function in anxiety
1987 • 467 citations
Serotonin and anxiety revisited
1988 • 253 citations
1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain
1989 • 229 citations
Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder
1988 • 225 citations
Neuroendocrine Effects ofM-Chlorophenylpiperazine, a Serotonin Agonist, in Humans
1985 • 181 citations
Behavioral indications for serotonin receptor hypersensitivity in panic disorder
1988 • 174 citations
Characteristics of people with infrequent panic attacks.
1985 • 155 citations
Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor mediated mechanism of action in humans
1986 • 142 citations
Characteristics of people with infrequent panic attacks.
1985 • 131 citations
(—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone
1981 • 111 citations
Effects ofm-chlorophenylpiperazine in normal subjects: a dose-response study
1990 • 90 citations
Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks
1987 • 32 citations